Drugmakers Are Slow To Prove Medicines That Got A Fast Track

Stalled confirmatory trials and lax enforcement plague the Food and Drug Administration's accelerated approval pathway for pharmaceuticals that target urgent medical needs.

Related Keywords

Washington , District Of Columbia , United States , Virginia , Boston , Massachusetts , Phoenix , Arizona , Rockville , Missouri , Ron Wyden , Phil Mccartin , Kristi Alcayaga , Allison Parks , Robert Califf , J Scott Applewhite , Suzanne Kreiter , Jacqueline Corrigan Curay , Mikkael Sekeres , Aaron Kesselheim , Rachel Sherman , Francesco Tallarico , Michaelb Thomas , Frank Young , Jovelle Tamayo , Los Angele , Covis Pharma , Gregg Gonsalves , Michael Alcayaga , Lorraine Heidke Mccartin , Walmart , Genentech , National Institutes Of Health , Harvard Medical School , Bonds , Sylvester Cancer Center At University Of Miami , Program On Regulation , Drug Administration In Rockville , Government Accountability Office , Boston Globe , National Institutes , Accelerated Approval Pathway , Los Angele Santa Monica , Drug Administration , Drug Evaluation , Brittany Bonds , New England , Getty Images , Sylvester Cancer Center , Brin Winterbottom ,